Venoarterial Extracorporeal Membrane Oxygenation After Autologous Stem Cell Transplantation With Pancytopenia: JACC Patient Care Pathways

J Am Coll Cardiol. 2023 Jul 25;82(4):374-378. doi: 10.1016/j.jacc.2023.04.038. Epub 2023 Jun 6.

Abstract

Venoarterial extracorporeal membrane oxygenation (VA-ECMO) provides temporary mechanical circulatory support and simultaneous extracorporeal gas exchange for acute cardiorespiratory failure. By providing circulatory support, VA-ECMO gives treatments time to reach optimal efficacy or may be used as a bridge to a more durable mechanical solution for patients with acute cardiopulmonary failure. It is commonly used when a readily reversible etiology of decompensation is identified with very strict inclusion criteria for extracorporeal cardiopulmonary resuscitation use. We present a unique case in which VA-ECMO/extracorporeal cardiopulmonary resuscitation was used after cardiac arrest with pulseless electrical activity in a patient with recurrent lymphoma of the left thigh with recent autologous stem cell transplant.

Keywords: extracorporeal cardiopulmonary resuscitation; extracorporeal membrane oxygenation; in-hospital cardiac arrest.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Cardiopulmonary Resuscitation*
  • Critical Pathways
  • Extracorporeal Membrane Oxygenation*
  • Heart Arrest* / etiology
  • Heart Arrest* / therapy
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Neoplasm Recurrence, Local
  • Pancytopenia*
  • Retrospective Studies
  • Transplantation, Autologous